Gaston-Dreyfus Remi - Insider Non-Derivative Transactions at Bionik Laboratories Corp. (BNKL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 13, 2023, Gaston-Dreyfus Remi's relationship to Bionik Laboratories Corp. (BNKL) is Director,TenPercentOwner, and currently has 4,917,749 shares of Common Stock, par value $0.001 per share.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BNKL insiders.
Data Source: SEC.
Gaston-Dreyfus Remi - Insider Non-Derivative Transactions of BNKL Common Stock, par value $0.001 per share
Gaston-Dreyfus Remi - Insider Non-Derivative Transactions at BNKL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 14, 2023 | C -- (Common Stock, par value $0.001 per share) | 3102878 | 0.6 | 4917749 |
| Jun 10, 2023 | P -- (Common Stock, par value $0.001 per share) | 180555 | 0.6 | 1814871 |